Published in Oncology Business Week, January 29th, 2006
However, just a few weeks later, results from the alpha-tocopherol, beta carotene (ATBC) cancer prevention trial showed that men with high blood levels of alpha-tocopherol (a form of vitamin E) had a lower risk of prostate cancer, reports Harvard Men's Health Watch.
"The ATBC research provides some support for vitamin E, but it's not conclusive," said Dr. Harvey Simon,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week